Home Cart Sign in  
Chemical Structure| 20537-88-6 Chemical Structure| 20537-88-6

Structure of Amifostine
CAS No.: 20537-88-6

Chemical Structure| 20537-88-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Amifostine is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.

Synonyms: WR2721

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Amifostine

CAS No. :20537-88-6
Formula : C5H15N2O3PS
M.W : 214.22
SMILES Code : OP(SCCNCCCN)(O)=O
Synonyms :
WR2721
MDL No. :MFCD00233058

Safety of Amifostine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312-P330-P501

Related Pathways of Amifostine

epigenetics

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05167370 Solid Tumors|Brain Tumors PHASE2 TERMINATED 2012-04-24 Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States Less <<
NCT01586117 Rectal Cancer PHASE2 UNKNOWN 2025-12-14 Radiation Oncology Depratment,... More >> Cancer Hospital, CAMS, Beijing, Beijing, 100021, China Less <<
NCT00078845 Breast Cancer|Lung Cancer|Neur... More >>otoxicity|Ovarian Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific Less << PHASE2 COMPLETED 2025-05-07 CCOP - Central Illinois, Decat... More >>ur, Illinois, 62526, United States|CCOP - Carle Cancer Center, Urbana, Illinois, 61801, United States|CCOP - Wichita, Wichita, Kansas, 67214-3882, United States|Christus St. Frances Cabrini Center for Cancer Care, Alexandria, Louisiana, 71301, United States|CCOP - Grand Rapids, Grand Rapids, Michigan, 49503, United States|CCOP - Kalamazoo, Kalamazoo, Michigan, 49007-3731, United States|CCOP - Kansas City, Kansas City, Missouri, 64131, United States|Cancer Research for the Ozarks, Springfield, Missouri, 65807, United States|CCOP - Columbus, Columbus, Ohio, 43215, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, 29303, United States|University of Texas M.D. Anderson CCOP Research Base, Houston, Texas, 77030-4009, United States|CCOP - Scott and White Hospital, Temple, Texas, 76508, United States|CCOP - Northwest, Tacoma, Washington, 98405-0986, United States|CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin, 54449, United States|All Saints Cancer Center at Wheaton Franciscan Healthcare, Racine, Wisconsin, 53405, United States Less <<
NCT00601198 Colorectal Cancer PHASE2 TERMINATED 2010-01-13 University of Cincinnati, Cinc... More >>innati, Ohio, 45267, United States Less <<
NCT00081315 Esophagitis|Pneumonitis|Non-Sm... More >>all Cell Lung Carcinoma Less << PHASE2 COMPLETED 2025-08-06 Cedars Sanai, Los Angeles, Cal... More >>ifornia, 90048, United States|Radiation Oncology Center, Sacramento, California, 95816, United States|The Center for Cancer Care, Torrington, Connecticut, 06790, United States|Florida Wellcare Alliance, Inverness, Florida, 34452, United States|Florida Community Cancer Center, New Port Richey, Florida, 34652, United States|Ormand Memorial Cancer Center, Ormand Beach, Florida, 32174, United States|Sarasota Memorial Hospital, Sarasota, Florida, 34239, United States|University Community Hospital-Center for Cancer Care, Tampa, Florida, 33613, United States|University of Kentucky, Lexington, Kentucky, 40536-0293, United States|St. Agnes Health Care, Baltimore, Maryland, 21229, United States|Center for Cancer & Blood Disorders, Bethesda, Maryland, 20817, United States|Chesapeake Oncology-Hematology Associates, Glen Burnie, Maryland, 21061, United States|St. John's Medical Research, Springfield, Missouri, 65807, United States|Cooper University Hospital, Camden, New Jersey, 08103, United States|Long Island Jewish Medical Center, New Hyde Park, New York, 11040, United States|Beth Israel Hospital, New York, New York, 10003, United States|Upstate NY Cancer R&E Foundation, Rochester, New York, 14623, United States|New Hanover Radiation, Wilmington, North Carolina, 28401, United States|Cancer Center of Upper Delaware Valley, Milford, Pennsylvania, 18337, United States|Montgomery Cancer Center, Norristown, Pennsylvania, 19401, United States|Charleston Cancer Center, Charleston, South Carolina, 29406, United States|The Center for Radiation Oncology, Danville, Virginia, 24541, United States|Providence Everett Medical Center, Everett, Washington, 98201, United States|Valley Medical Center, Renton, Washington, 98055, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.67mL

0.93mL

0.47mL

23.34mL

4.67mL

2.33mL

46.68mL

9.34mL

4.67mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories